Oncoinvent ASA
ONCIN
Rank in Stocks
#27363
Oncoinvent ASA, a clinical-stage firm based in Oslo, Norway, is dedicated to... Oncoinvent ASA, a clinical-stage firm based in Oslo, Norway, is dedicated to developing innovative radiopharmaceutical treatments for various cancers. Its primary therapeutic agent is Radspherin, an alpha-emitting radiotherapeutic, which is currently undergoing investigation in two Phase 1/2a and one randomized Phase 2 clinical trials. This promising candidate is designed to target and treat malignancies that have metastasized to body cavities, specifically including the peritoneum.
Share Price
$7.09
Market Cap
$31.73M
Change (1 day)
0.30%
Change (1 year)
6,326.07%
Country
NO
Trade Oncoinvent ASA (ONCIN)
Category
Healthcare
Stock split history for Oncoinvent ASA (ONCIN)
Oncoinvent ASA stock (symbol: ONCIN) underwent a total of 0 stock splits.
The most recent stock split occurred on Oct 20, 2026.
One ONCIN share bought prior to Oct 20, 2026 would equal to 0 ONCIN shares today.
The most recent stock split occurred on Oct 20, 2026.
One ONCIN share bought prior to Oct 20, 2026 would equal to 0 ONCIN shares today.
Stock split list
| Year | Split | Multiple | Cumulative Multiple |
|---|---|---|---|
| Not enough data for the provided dates. | |||
Stock splits for similar companies or competitors
| Company | Number of stock splits | Cumulative Multiple | Country |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
